Prader-Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review.
Butler MG.
Int J Mol Sci. 2023 Feb 21;24(5):4271. doi: 10.3390/ijms24054271.
PMID:36901699
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstrom syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period.
Haqq AM, Chung WK, Dollfus H, Haws RM, Martos-Moreno GÁ, Poitou C, Yanovski JA, Mittleman RS, Yuan G, Forsythe E, Clément K, Argente J.
Association of obesity or metabolic syndrome with various allergic diseases: An overview of reviews.
Kuniyoshi Y, Tsujimoto Y, Banno M, Taito S, Ariie T, Kimoto T.
Obes Rev. 2025 Mar;26(3):e13862. doi: 10.1111/obr.13862. Epub 2024 Dec 11.
PMID:39663640
Understanding obesity in children with 22q11.2 deletion syndrome.
Sarli WM, Cerutti M, Pontone M, Guarnieri V, Soldovieri S, Giotta M, Ricci S, Azzari C, Stagi S.
Front Endocrinol (Lausanne). 2025 Jul 31;16:1628796. doi: 10.3389/fendo.2025.1628796. eCollection 2025.
PMID:40822943
[Improved Care and Treatment Options for Patients with Hyperphagia-Associated Obesity in Bardet-Biedl Syndrome].
Cetiner M, Bergmann C, Bettendorf M, Faust J, Gäckler A, Gillissen B, Hansen M, Kerber M, Klaus G, König J, Kühlewein L, Oh J, Richter-Unruh A, von Schnurbein J, Wabitsch M, Weihrauch-Blüher S, Pape L.
Klin Padiatr. 2024 Sep;236(5):269-279. doi: 10.1055/a-2251-5382. Epub 2024 Mar 8.